Despite causing necrotic wounds that lead to thousands of preventable amputations annually, the veterinary sedative xylazine remains completely unscheduled at the federal level—creating a regulatory void that traffickers exploit to legally import a substance now
We bring you the latest updates from The Regulatory Review through a simple and fast subscription.
We can deliver your news in your inbox, on your phone or you can read them here on this website on your personal news page.
Unsubscribe at any time without hassle.
The Regulatory Review's title: The Regulatory Review